Literature DB >> 31084547

Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely.

Paolo Spallarossa1, Giacomo Tini1,2, Matteo Sarocchi1,2, Eleonora Arboscello1, Francesco Grossi3, Paola Queirolo1, Gabriele Zoppoli1,2, Pietro Ameri1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31084547     DOI： 10.1200/JCO.18.02464

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

Review 1.  [Novel cancer treatment and the cardiovascular risk : What should cardiologists know?]

Authors:  Matthias Totzeck; Tienush Rassaf
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

2.  Real-world cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a retrospective controlled cohort study.

Authors:  Chuan Zhang; Zhulu Chen; Chunhua Mo; Diansha Gao; Yuxi Zhu; Shu Qin; Zhong Zuo
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

3.  Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors.

Authors:  Ai-Tram N Bui; Kevin Tyan; Anita Giobbie-Hurder; Isaac A Klein; Michael P Manos; Leyre Zubiri; Kerry Reynolds; Shilpa Grover; Gerald L Weinhouse; Patrick A Ott; Nicole R LeBoeuf; Osama Rahma
Journal:  J Immunother Precis Oncol       Date:  2021-05-14

Review 4.  Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.

Authors:  Magdalena Zaborowska-Szmit; Maciej Krzakowski; Dariusz M Kowalski; Sebastian Szmit
Journal:  J Clin Med       Date:  2020-04-27       Impact factor: 4.241

5.  CDK4/6 inhibition protects normal cells against cancer therapy-induced damage.

Authors:  Ettickan Boopathi; Chellappagounder Thangavel
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

6.  Clinical manifestation and management of immune checkpoint inhibitor-associated cardiotoxicity.

Authors:  Xiaoxiao Guo; Hanping Wang; Jiaxin Zhou; Yue Li; Lian Duan; Xiaoyan Si; Li Zhang; Ligang Fang; Li Zhang
Journal:  Thorac Cancer       Date:  2019-12-17       Impact factor: 3.500

7.  Immune Checkpoint Inhibitor-Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?

Authors:  Lova Sun; Charu Aggarwal; Roger B Cohen
Journal:  JACC CardioOncol       Date:  2019-12-17

Review 8.  An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors.

Authors:  Roberta Esposito; Teresa Fedele; Silvia Orefice; Vittoria Cuomo; Maria Prastaro; Mario Enrico Canonico; Federica Ilardi; Francesco De Stefano; Ludovica Fiorillo; Ciro Santoro; Giovanni Esposito
Journal:  Biomolecules       Date:  2021-05-22

Review 9.  Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.

Authors:  Nicolas Palaskas; Juan Lopez-Mattei; Jean Bernard Durand; Cezar Iliescu; Anita Deswal
Journal:  J Am Heart Assoc       Date:  2020-01-21       Impact factor: 5.501

Review 10.  [Clinical Diagnosis and Treatment Recommendations for Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor].

Authors:  Xiaoxiao Guo; Hanping Wang; Jiaxin Zhou; Lian Duan; Yue Li; Xiaoyan Si; Li Zhang; Ligang Fang; Li Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.